Priyanka Raheja/LinkedIn
Feb 14, 2026, 14:30
Priyanka Raheja։ The Impact of Heavy Menstrual Bleeding in Rare Clotting Factor Deficiencies
Priyanka Raheja, Director at The Royal London Hospital Haemophilia Comprehensive Care Centre, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“No one better to tell us about the impact of heavy menstrual bleeding in rare clotting factor deficiencies, than those with lived experience.
Here is a short piece we put together to share the patient’s voice.”
Title: Dealing with heavy menstrual bleeding in very rare bleeding disorders: from a patient’s perspective
Authors: Priyanka Raheja, Rezan Abdul-Kadir, Maja Johanne Søndergaard Knudsen, Christina Burgess, Saskia E.M. Schols
Read the Full Article on RPTH Journal.
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC